Navigation Links
CEL-SCI Corporation Releases Letter to Shareholders
Date:2/20/2009

VIENNA, Va., Feb. 20 /PRNewswire-FirstCall/ -- The following letter is being released by CEL-SCI Corporation (NYSE Alternext US: CVM) to its shareholders:

Dear Fellow Shareholders:

I am writing today to provide you with a review of 2008 as well as to update you on our plans for dealing with the current financial downturn. In looking back at the last year, I see a year of meaningful accomplishments which put CEL-SCI in a valuable position, and among a very select group of companies that have a completely novel medicine with blockbuster potential ready to go into a Phase III clinical trial.

Key Company highlights of 2008:

  • We extended our Multikine licensing agreement with Orient EuroPharma of Taiwan (a leading pharmaceutical company in Taiwan) to cover additional countries in the Far East. Orient EuroPharma will also participate in and pay for part of our Phase III trial.

  • At the end of 2008 we took delivery of the Multikine manufacturing facility in Baltimore. This facility will supply Multikine for the Phase III clinical trial as well as commercial s
    '/>"/>

SOURCE CEL-SCI Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. CEL-SCI Announces Expansion of Exclusive Licensing Agreement for Cancer Drug Multikine
2. CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect
3. CEL-SCI Expects to Take Delivery of New Manufacturing Facility on October 8, 2008
4. Data Suggest CEL-SCIs CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis
5. CEL-SCI Corporation Reports First Quarter Financial Results
6. CEL-SCI Corporation Announces 2007 Financial Results
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
8. CEL-SCI to Present at Rodman & Renshaw 9th Annual Healthcare Conference
9. CEL-SCI CEO to Present at the International Society for Pharmaceutical Engineering 2007 Chesapeake BioShowcase
10. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
11. CEL-SCI CEO to Present Tomorrow at the Biotech / Pharma / Healthcare On-Line Forum

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... Sleep Solutions®, Inc. (SSI),...testing and evaluation of sleep-disordered breathi...M.D., as its chief executive officer. Hassett was...ing its growth from a $250 million healthcare hold... total population health, and its subsequent sale ...
(Date:12/1/2009)...wswire/ -- At this year,s annual meeting of the Ra...Philips Electronics ( PHG, AEX: PHI) will introduc...s that provides radiologists the ability to review...elp drive quality and efficiency. Showcasing its ...ight new capabilities for its portfolio of diagnos...
(Date:12/1/2009)... Exagen Diagnostics, Inc., a molec...ps and markets proprietary genomic tests, today an... of the company,s board of directors and chief exe...nn was managing partner of Windamere Venture Partn...al companies including Prometheus Laboratories, Sa...
Breaking Medicine Technology:Sleep Solutions, Inc. Names Richard Hassett, M.D., New CEO 2Sleep Solutions, Inc. Names Richard Hassett, M.D., New CEO 3Philips Introduces Multi-Modality Breast Workspace to Complement Comprehensive Portfolio of Diagnostic Imaging Solutions for Breast Care 2Philips Introduces Multi-Modality Breast Workspace to Complement Comprehensive Portfolio of Diagnostic Imaging Solutions for Breast Care 3Philips Introduces Multi-Modality Breast Workspace to Complement Comprehensive Portfolio of Diagnostic Imaging Solutions for Breast Care 4Scott Glenn Joins Exagen Diagnostics as Chairman and CEO 2The Rasansky Law Firm Announces Dallas Day Care Death Lawsuit 3B State Investigation Finds Evidence of Negligence at Woodbridge Day School 60768 1The Rasansky Law Firm Announces Dallas Day Care Death Lawsuit 3B State Investigation Finds Evidence of Negligence at Woodbridge Day School 60768 2Beike Biotechnology Invests in Leading Japanese Regenerative Medicine Co Biomaster Inc 60766 1Beike Biotechnology Invests in Leading Japanese Regenerative Medicine Co Biomaster Inc 60766 2Beike Biotechnology Invests in Leading Japanese Regenerative Medicine Co Biomaster Inc 60766 3Beike Biotechnology Invests in Leading Japanese Regenerative Medicine Co Biomaster Inc 60766 4Qualsecs Wholly Owned Subsidiary Receives Order From New Jersey Based DMC Athletics and Rehabilitation 60764 1Qualsecs Wholly Owned Subsidiary Receives Order From New Jersey Based DMC Athletics and Rehabilitation 60764 2
...orporated (Nasdaq: VICL ),today is presenting exp...strating that the company,s Vaxfectin(R) adjuvant ...d infectious disease vaccines and,peptide-based ca...Vical,s,Senior Vice President of Product Developme... 8, at the World Vaccine Congress (Lyon, France - ...
...ealth Care and its Great,Lakes Cancer Institute ar...nds to share the latest work underway around the g...nts. The October 11th symposium, hosted by,McLaren..., M.D., an,award-winning surgical oncologist whose...er has gained worldwide recognition and has evolve...
Other Medicine Technology:Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 2Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 3Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 4Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 5News Media Advisory: World's Leading Surgical Oncologists to Gather at McLaren Regional Medical Center to Present Latest Work on Breast, Gastrointestinal Cancer Treatments 2
(Date:12/1/2009)...est rates seen in Central and South America, study...ws) -- About 50 percent of intensive care unit pat...their risk of dying in the hospital, a new study f...a single day (May 8, 2007) on 13,796 patients, age...y found that 51 percent of patients were classifie...
(Date:12/1/2009)...ILADELPHIA (December 1, 2009) Wistar Institute r...f Pennsylvania and New York University have identi...cate early-stage lung tumors in people at high ris...hed online December 1 in Cancer Research , a jour...h, could lead to a simple blood test to detect lun...
(Date:12/1/2009)... , RESEARCH TRIANGLE PARK, N.C., Dec. 1 /P...itiated in 2001 and have expanded over the years s...lly. The facility which was originally set up in a...armacy services, as part of the suite of services ... industry as a valuable offering. ,, The pharma...
(Date:12/1/2009)... , WASHINGTON, Dec. 1 /PRNewswire-USNewswire...CDHPs) are more likely than those with traditional...haviors, to be more engaged in wellness programs, ...centives matter in holding down costs, according t... Employee Benefit Research Institute (EBRI). ,...
(Date:12/1/2009)... , FORT LAUDERDALE, Fla., Dec. 1 /PRNewswir... patient enrollment in the randomized clinical tri...tent (Combo Stent). ,, A prospective, randomize... valuation of an ablu M inal sirolimus coat ED ...tients at up to 20 sites in Asia, Australia, Europ...
Breaking Medicine News(10 mins):Health News:Half of ICU Patients Suffer From Infections 2Health News:Wistar-led research team discovers genetic pattern that indicates early-stage lung cancer 2Health News:Wistar-led research team discovers genetic pattern that indicates early-stage lung cancer 3Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 2Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 3Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 4Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 2Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 3Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 4
...l elections in US. The issue is raging in neighbou...ticians to get away with glib talk. As the country...quent on the governments commitment to medicare, a...s need a credit card'' and "Where did medicare go?...
...nxiously awaiting reports later this week on wheth...e deadly viral hemorrhagic septicemia. Of...rces (DNR) confirmed that two fish from an adjoini...ke Butte des Morts is the first occurrence of the ...
...pressed over the housing together of two convicted...rs Robbie Sebastian Wheeler, 43, and his boyfrien...ether in Hakea jail, in West Australia. The t...ed to murder the boy and dispose of his body. ...
...rculosis, researchers say. A study of 131 ...ity of the body to inhibit the growth of the bacte...f BBC News. Until now no study has evaluat...cipants and infected with mycobacteria. Th...
...udents with asthma who participated in a specially...ported fewer days and nights with symptoms, fewer...vity, and less hospitalization for asthma during a...gist for the Henry Ford Health System in Detroit, ...
...stroke in the past two months across Orissa, offic... been reported from the southern district of Ganja...icts of Balasore, Kandhamal, Kendrapada, Nuapada a... from various parts of the state. These are being ...
Other Medicine News:Health News:Cancer Patients Turn Their Backs on Canadian Health Minister 2Health News:Deadly Virus Hits Popular Lake in US 2Health News:Outrage Against Gay PartnersInCrime Kept Together 2Health News:Web-based Asthma Program Improves Disease Management for Black Students 2
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
Medicine Products: